JPH0368601A - Immobil xized cyclodextrin - Google Patents
Immobil xized cyclodextrinInfo
- Publication number
- JPH0368601A JPH0368601A JP20600989A JP20600989A JPH0368601A JP H0368601 A JPH0368601 A JP H0368601A JP 20600989 A JP20600989 A JP 20600989A JP 20600989 A JP20600989 A JP 20600989A JP H0368601 A JPH0368601 A JP H0368601A
- Authority
- JP
- Japan
- Prior art keywords
- cyclodextrin
- branched
- carrier
- compd
- aminated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920000858 Cyclodextrin Polymers 0.000 title claims abstract description 71
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title claims abstract description 47
- 125000003277 amino group Chemical group 0.000 claims abstract description 18
- 239000000126 substance Substances 0.000 claims abstract description 8
- 229960004853 betadex Drugs 0.000 claims abstract description 6
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims abstract description 5
- 150000004676 glycans Chemical class 0.000 claims abstract description 4
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 4
- 239000005017 polysaccharide Substances 0.000 claims abstract description 4
- 108090000623 proteins and genes Chemical class 0.000 claims abstract description 4
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 4
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 claims abstract description 3
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 claims abstract description 3
- 229940043377 alpha-cyclodextrin Drugs 0.000 claims abstract description 3
- 150000001720 carbohydrates Chemical group 0.000 claims abstract description 3
- 125000004122 cyclic group Chemical group 0.000 claims abstract description 3
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 claims abstract description 3
- 229940080345 gamma-cyclodextrin Drugs 0.000 claims abstract description 3
- 229920001059 synthetic polymer Polymers 0.000 claims description 4
- 125000003172 aldehyde group Chemical group 0.000 abstract description 9
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 abstract description 8
- 238000011084 recovery Methods 0.000 abstract description 2
- 239000002904 solvent Substances 0.000 abstract 1
- 229940097362 cyclodextrins Drugs 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 229920002101 Chitin Polymers 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- -1 cyclic oligosaccharide Chemical class 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 5
- 239000003957 anion exchange resin Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 239000001116 FEMA 4028 Substances 0.000 description 4
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 4
- 229920001429 chelating resin Polymers 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 4
- 239000013076 target substance Substances 0.000 description 4
- 229920000178 Acrylic resin Polymers 0.000 description 3
- 239000004925 Acrylic resin Substances 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 239000003431 cross linking reagent Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000021736 acetylation Effects 0.000 description 2
- 238000006640 acetylation reaction Methods 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 2
- 229940052490 naringin Drugs 0.000 description 2
- 229930019673 naringin Natural products 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 108010025880 Cyclomaltodextrin glucanotransferase Proteins 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940094517 chondroitin 4-sulfate Drugs 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 230000000850 deacetylating effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000015201 grapefruit juice Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 108010001078 naringinase Proteins 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000724 poly(L-arginine) polymer Polymers 0.000 description 1
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229940048914 protamine Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は新規な固定化サイクロデキストリンに関する。[Detailed description of the invention] [Industrial application field] The present invention relates to novel immobilized cyclodextrins.
サイクロデキストリンは、澱粉にサイクロデキストリン
グルカノトランスフェラーゼを作用させることによって
得られ、6個以上のグルコースがα−1,4結合した環
状オリゴ糖である。グルコース環が6個のα−サイクロ
デキストリン、7個のβ−サイクロデキストリン及び8
個のγ−サイクロデキストリンが一船に知られており、
各々6〜lO人の空洞を有している。この空洞は各種の
物質を取り込む性質がある。その利用分野は食品のみな
らず薬品、化粧品等多岐に亘っている。Cyclodextrin is obtained by treating starch with cyclodextrin glucanotransferase, and is a cyclic oligosaccharide in which six or more glucose units are linked with α-1,4 bonds. α-cyclodextrin with 6 glucose rings, β-cyclodextrin with 7 glucose rings, and 8
A number of γ-cyclodextrins are known in one ship,
Each has 6 to 10 cavities. This cavity has the property of taking in various substances. The field of use is wide-ranging, including not only foods but also medicines and cosmetics.
しかしながら、サイクロデキストリンは水溶液中で利用
する場合溶解性が低く、このため用途が著しく制限され
ている。この欠点を改善する為、サイクロデキストリン
環にグルコース分子をα−1,6結合させたグルコシル
サイクロデキストリン、マルトースをα−1,6結合さ
せたマルトシルサイクロデキストリン等の分枝サイクロ
デキストリンの製造について研究がなされ、効率的な製
造技術が公開特許公報昭61−92592号、公開特許
公報昭61−70996号等に開示されている。However, cyclodextrins have low solubility when utilized in aqueous solutions, which severely limits their applications. In order to improve this drawback, research has been conducted on the production of branched cyclodextrins such as glucosylcyclodextrin, which has glucose molecules linked to the cyclodextrin ring with α-1,6 bonds, and maltosylcyclodextrin, which has maltose linked with α-1,6 bonds. Efficient manufacturing techniques have been disclosed in Japanese Patent Publications No. 61-92592, Japanese Patent Publication No. 70996/1987, and the like.
分岐サイクロデキストリンの製造により溶解性は大幅に
改善されたものの、その用途並びに使用法については従
来のサイクロデキストリンと基本的には大差がない。即
ち、サイクロデキストリンの場合と同様に、対象物質を
水溶液中で分枝サイクロデキストリンの空洞に包接し、
乾燥あるいは濃縮等の工程により粉末化し、包接された
対象物質を回収利用するという処理方法が一般的である
。Although the solubility has been greatly improved by producing branched cyclodextrins, there is basically no difference in their uses and usage from conventional cyclodextrins. That is, as in the case of cyclodextrin, the target substance is included in the cavity of branched cyclodextrin in an aqueous solution,
A common treatment method is to collect and utilize the clathrated target substance after turning it into powder through a process such as drying or concentration.
しかし水溶液中の対象物質を包接させた分枝サイクロデ
キストリンを系外に分離して利用することは取り扱い上
困難であり、費用も高くつく。However, it is difficult to handle and use the branched cyclodextrin containing the target substance in an aqueous solution by separating it outside the system and is expensive.
そこでサイクロデキストリンを固定化する技術が開発さ
れ、水溶液中の対象物質の回収・分取が可能となってい
る。例えばサイクロデキストリンをエピクロルヒドリン
等の架橋剤で架橋させてビーズ状ポリマーを形成させて
、グレープフルーツ果汁及びネーブル果汁中の苦味成分
を吸着減量させる方法CJ、^gric、 Food
Chem、 32.832−836 (1984))、
アクリル系の樹脂担体にスペーサーを介してサイクロデ
キストリンを固定化させたもの、アクリル系樹脂を架橋
剤としてサイクロデキストリンを架橋したもの、シリカ
系の担体にスペーサーを介してサイクロデキストリンを
固定化させたもの等がある。Therefore, a technology to immobilize cyclodextrin has been developed, making it possible to recover and separate target substances from aqueous solutions. For example, a method of cross-linking cyclodextrin with a cross-linking agent such as epichlorohydrin to form a bead-like polymer to adsorb and reduce bitter components in grapefruit juice and navel juiceCJ, ^gric, Food
Chem, 32.832-836 (1984)),
Cyclodextrin is immobilized on an acrylic resin carrier via a spacer, cyclodextrin is crosslinked using an acrylic resin as a crosslinking agent, and cyclodextrin is immobilized on a silica carrier via a spacer. etc.
しかし、スペーサーを介してサイクロデキストリンを固
定化したものは工業的に大量に使用する場合価格的に問
題がある。又、アクリル系樹脂で架橋したビーズ状のサ
イクロデキストリンポリマーを水溶液中の有用成分の吸
着分取に使用する場合、ビーズ中心部に吸着された成分
の回収には時間を要する。更にはエピクロルヒドリン等
の架橋剤で得られるサイクロデキストリンポリマーは安
全性の点で問題がある。However, when cyclodextrin is immobilized via a spacer, there is a problem in terms of cost when used industrially in large quantities. Furthermore, when a bead-shaped cyclodextrin polymer crosslinked with an acrylic resin is used for adsorption and fractionation of useful components in an aqueous solution, it takes time to recover the components adsorbed at the center of the beads. Furthermore, cyclodextrin polymers obtained with crosslinking agents such as epichlorohydrin have problems in terms of safety.
本発明の目的は、吸着された成分の回収が容易であり、
安全性の点で問題のない新規な固定化サイクロデキスト
リンを提供することである。The purpose of the present invention is to facilitate recovery of adsorbed components,
An object of the present invention is to provide a novel immobilized cyclodextrin that has no problems in terms of safety.
上記目的は、アミノ基を有する担体に、分枝サイクロデ
キストリンの分枝部のみをアルデヒド化させたアルデヒ
ド化分枝サイクロデキストリンを化学結合させてなる固
定化サイクロデキス) Uンにより達成される。The above object is achieved by immobilized cyclodextrin, which is obtained by chemically bonding an aldehyded branched cyclodextrin, in which only the branched portion of the branched cyclodextrin is aldehyded, to a carrier having an amino group.
本発明に使用される分枝サイクロデキストリンは分枝部
がグルコシル、マルトシル、バノシル等、隣接するOH
基を有する糖類であり、環状部がαβ−又はγ−サイク
ロデキストリンのいずれかから成るものが好ましい。こ
れらは単分枝サイクロデキストリン、同種複分枝サイク
ロデキストリン、異種複分枝サイクロデキストリンのい
ずれでもよい。The branched cyclodextrin used in the present invention has a branch moiety such as glucosyl, maltosyl, vanosyl, etc., adjacent OH
Preferably, the saccharide has a cyclic group consisting of either αβ- or γ-cyclodextrin. These may be mono-branched cyclodextrins, homologous multi-branched cyclodextrins, or heterogeneous multi-branched cyclodextrins.
またアミノ基を有する担体としては、アミノ基含有多糖
類又は蛋白質又はアミノ基含有合成高分子物質が挙げら
れる。具体例としては、キチン、キトサン等の天然物、
弱塩基性陰イオン交換樹脂等の合成高分子物質がある。Examples of carriers having amino groups include amino group-containing polysaccharides or proteins, and amino group-containing synthetic polymer substances. Specific examples include natural products such as chitin and chitosan;
There are synthetic polymer substances such as weakly basic anion exchange resins.
そのほか、アミノ基含有多糖類としては、プロテオグル
カン類のヒアルロン酸、コンドロイチン硫酸(コンドロ
イチン4−硫酸、コンドロイチン6−硫酸)、デルマタ
ン硫酸、ケラタン硫酸等及びそれらの脱アセチル化物等
、タンパク質としてはアルブミン、グロブリン、ブロラ
□ン、グリテリン、ヒストン、プロタミン、カゼイン、
ゼラチン、コラーゲン等、アミノ基含有合成高分子とし
てはポリアクリルアミド、ポリメタクリルアミド、ポリ
アミドアミン類、片末端にアミノ基を有する2−ヒドロ
キシエチルメタクリレート、合成ポリペプチド類(ポリ
ーL−リジン、ポリーL−アルギニン)等が挙げられる
。In addition, amino group-containing polysaccharides include proteoglucans such as hyaluronic acid, chondroitin sulfate (chondroitin 4-sulfate, chondroitin 6-sulfate), dermatan sulfate, keratan sulfate, and their deacetylated products; proteins include albumin, Globulin, brolan, glycerin, histone, protamine, casein,
Synthetic polymers containing amino groups such as gelatin and collagen include polyacrylamide, polymethacrylamide, polyamide amines, 2-hydroxyethyl methacrylate having an amino group at one end, and synthetic polypeptides (poly L-lysine, poly L- arginine), etc.
本発明に使用されるアルデヒド化分枝サイクロデキスト
リンを製造するには、まず分枝サイクロデキストリンに
適当なゲスト化合物を包接させる。In order to produce the aldehydated branched cyclodextrin used in the present invention, a suitable guest compound is first included in the branched cyclodextrin.
このようなゲスト化合物の例としては、ブタノール、シ
クロヘキサン、シクロヘキサノール、トルエンなどが挙
げられる。分枝サイクロデキストリン1モルに対し、ゲ
スト化合物0.1〜0.3モル程度使用するのが好まし
い。分枝サイクロデキストリンとゲスト化合物を混合し
、常温で1〜24時間放置するとゲスト化合物が包接さ
れる。Examples of such guest compounds include butanol, cyclohexane, cyclohexanol, toluene, and the like. It is preferable to use about 0.1 to 0.3 mol of the guest compound per 1 mol of the branched cyclodextrin. When a branched cyclodextrin and a guest compound are mixed and left at room temperature for 1 to 24 hours, the guest compound is included.
過剰のゲスト化合物を必要により除去した後、次にこれ
を過ヨウ素酸酸化処理する。過ヨウ素酸、メタ過ヨウ素
酸ナトリウム等の過ヨウ素酸塩をo、 o o t〜1
モルとなるように加え、水性溶媒中、0〜20℃で0,
5〜10時間処理することにより、分枝サイクロデキス
トリンの分枝部のみがアルデヒド化される。グルコシル
サイクロデキストリンを用いた場合には2個のアルデヒ
ド基が、マルトシルサイクロデキストリンを用いた場合
には2個または4個のアルデヒド基が、バノシルサイク
ロデキストリンを用いた場合には2個、4個または6個
のアルデヒド基が形成される。After removing excess guest compound as necessary, this is then subjected to periodic acid oxidation treatment. periodic acid, periodate salt such as sodium metaperiodate, o, o o t~1
0 to 20°C in an aqueous solvent.
By treating for 5 to 10 hours, only the branched portions of the branched cyclodextrin are converted into aldehydes. 2 aldehyde groups when using glucosyl cyclodextrin, 2 or 4 aldehyde groups when using maltosyl cyclodextrin, 2 when using vanosyl cyclodextrin, 4 or 6 aldehyde groups are formed.
次いでエチレングリコール等を加えて過剰の過ヨウ素酸
を分解した後、活性炭カラムに吸着させて水洗する。水
洗後、15〜50%エタノールで溶出させてi!縮、再
結晶により精製する。Next, excess periodic acid is decomposed by adding ethylene glycol, etc., and then adsorbed onto an activated carbon column and washed with water. After washing with water, elute with 15-50% ethanol and i! Purify by shrinkage and recrystallization.
こうして得られたアルデヒド化分枝サイクロデキストリ
ンとアミノ基を含有する担体を水性媒体中で数時間反応
させると、アルデヒドとアミンが容易に反応し、イミノ
結合(−CH=N−)を介して分枝サイクロデキストリ
ンが担体に固定化される。アルデヒド基対アミノ基のモ
ル比は特に制限されないが、−船に1:1が適当である
。固定化反応終了後、過剰のアルデヒド基は水素化ホウ
素ナトリウム等で還元処理し、アミノ基はアセチル化処
理することにより保護しておくことが望ましい。When the aldehyde-branched cyclodextrin thus obtained and the carrier containing an amino group are reacted in an aqueous medium for several hours, the aldehyde and amine easily react and separate via the imino bond (-CH=N-). A branched cyclodextrin is immobilized on a carrier. The molar ratio of aldehyde groups to amino groups is not particularly limited, but is suitably 1:1. After completion of the immobilization reaction, it is desirable to reduce excess aldehyde groups with sodium borohydride or the like, and protect amino groups by acetylation.
〔発明の効果]
サイクロデキストリンの包接機能を保持したまま、分枝
部のみがアルデヒド化された分枝サイクロデキストリン
をアミノ基含有担体に化学的に結合させてなる本発明の
固定化サイクロデキス) IJンは、製造が安価かつ容
易であり、担体表面にサイクロデキストリンが固定化さ
れているため、有用物質や有害物質の回収あるいは除去
が有効かつ容易に行われる。また、キチン、キトサン等
の天然物質を担体として使用した場合には安全性の点で
も問題がない。さらに本発明の固定化サイクロデキスト
リンは、従来のイオン交換樹脂等と同様に、カラムに充
填して使用することが可能であり、水溶液中の有用物質
や有害物質を連続的に吸着、回収することができる。[Effects of the Invention] The immobilized cyclodextrin of the present invention is obtained by chemically bonding a branched cyclodextrin in which only the branched portion is aldehyded to an amino group-containing carrier while retaining the inclusion function of the cyclodextrin. Since cyclodextrin is cheap and easy to manufacture, and cyclodextrin is immobilized on the surface of the carrier, useful and harmful substances can be effectively and easily recovered or removed. Furthermore, when natural substances such as chitin and chitosan are used as carriers, there is no problem in terms of safety. Furthermore, the immobilized cyclodextrin of the present invention can be used by filling a column in the same way as conventional ion exchange resins, etc., and can continuously adsorb and recover useful substances and harmful substances in aqueous solutions. I can do it.
実施例1
グルコシルβ−サイクロデキストリン1.7 gにシク
ロヘキサン20−を加え一夜放置し包接化した。これに
蒸留水950−を加えよく撹拌して、0.1モルのメタ
過ヨウ素酸す) IJウム溶液5〇−を添加し、暗所で
5℃で3時間静置して過ヨウ素酸酸化させた。Example 1 20-cyclohexane was added to 1.7 g of glucosyl β-cyclodextrin and left overnight to form inclusion. Add 950 ml of distilled water to this, stir well, add 0.1 mol of meta-periodic acid, add 50 ml of IJium solution, and let it stand at 5°C for 3 hours in the dark to oxidize with periodic acid. I let it happen.
次にエチレングリコール2rR1を加えて15分間放置
して過剰のメタ過ヨウ素酸ナトリウムを分解させた。活
性炭カラムで精製して15〜50%エタノールで溶出さ
せ、濃縮乾固及び再結晶により、側鎖にアルデヒド基を
有するβ−サイクロデキストリン1. Ogを得た。こ
れを蒸留水400−に溶解せしめ、一部を脱アセチル化
させたキチンl。Next, ethylene glycol 2rR1 was added and left to stand for 15 minutes to decompose excess sodium metaperiodate. Purification with an activated carbon column, elution with 15-50% ethanol, concentration to dryness and recrystallization yields β-cyclodextrin having an aldehyde group in the side chain.1. Obtained Og. Chitin 1 was obtained by dissolving this in 400ml of distilled water and partially deacetylating it.
gを加え、3時間マグネティックスターラーで撹拌し、
反応させた。遠心分離により面にβ−サイクロデキスト
リンが固定化されたキチン10.5 gを得た。本島の
キチン表面におけるサイクロデキストリンの重量含有率
は5%であった。Add g and stir with a magnetic stirrer for 3 hours.
Made it react. By centrifugation, 10.5 g of chitin with β-cyclodextrin immobilized on its surface was obtained. The weight content of cyclodextrin on the chitin surface of the main island was 5%.
本島の余剰のアミノ基が存在しないようにアセチル化処
理した後、水晶10gをカラムに充填し、0、1%ナリ
ンギン30−を通液させたところ、対照(余剰のアミノ
基が存在しない、一部を脱アセチル化させたキチン)に
比ベナリンギンを約29%多く除去した。After acetylation treatment to eliminate excess amino groups on the main island, 10 g of crystal was packed in a column and 0.1% naringin 30- was passed through the column. Approximately 29% more benaringin was removed compared to chitin, which has been deacetylated.
ナリンギナーゼを作用させ(40℃、20分間)生成す
るグルコースをグルコースオキシダーゼ法で比色定量す
ることによりナリンギンの量を求めた。The amount of naringin was determined by colorimetrically quantifying the glucose produced by the action of naringinase (at 40° C. for 20 minutes) using the glucose oxidase method.
実施例2
グルコシルT−サイクロデキストリンの分枝部を過ヨウ
素酸酸化して得られる側鎖にアルデヒド基を有するT−
サイクロデキストリン3gを蒸留水500m1!に溶解
させた。これに弱塩基性陰イオン交換樹脂アンバーライ
トrRA−45を30g添加し、3時間スターラーで撹
拌しながら反応させた。Example 2 T-glucosyl T-cyclodextrin having an aldehyde group in its side chain obtained by periodic acid oxidation of the branched portion of T-cyclodextrin
3g of cyclodextrin in 500ml of distilled water! It was dissolved in 30g of weakly basic anion exchange resin Amberlite rRA-45 was added to this, and the mixture was reacted for 3 hours while stirring with a stirrer.
濾別により、分枝T−サイクロデキストリンが固定化さ
れた弱塩基性陰イオン交換樹脂アンバーライトIRA−
45(30,6g)を得た。反応前後における上澄中の
アルデヒド化T−サイクロデキストリンの量をフェノー
ル硫酸法により測定したところ、反応後25%減少して
いた。したがって、使用したアルデヒド化T−サイクロ
デキストリンの25%が上記樹脂に結合していることが
わかる。Weakly basic anion exchange resin Amberlite IRA- on which branched T-cyclodextrin is immobilized by filtration.
45 (30.6 g) was obtained. When the amount of aldehyded T-cyclodextrin in the supernatant before and after the reaction was measured by the phenol-sulfuric acid method, it was found to have decreased by 25% after the reaction. Therefore, it can be seen that 25% of the aldehyded T-cyclodextrin used is bound to the resin.
又、水晶及び弱塩基性陰イオン交換樹脂アンバーライト
I RA−45の全アミン量を51gg1a。In addition, the total amine content of crystal and weakly basic anion exchange resin Amberlite I RA-45 was 51 gg1a.
Hanna、 Kervenski法で確認したところ
、水晶の全アミンモル数/試料(g)は1.91X10
−’で、対照の全アミンモル数/試料(g)は2.79
X10−4であった。従って、弱塩基性陰イオン交換
樹脂アンバーライトIRA−45のアミノ基がシップ塩
基反応により減少していることが*認された。When confirmed by the Hanna and Kervenski method, the total number of amine moles in the crystal/sample (g) is 1.91X10
-', total amine moles of control/sample (g) is 2.79
It was X10-4. Therefore, it was confirmed that the amino groups of the weakly basic anion exchange resin Amberlite IRA-45 were reduced due to the Shipp base reaction.
第1表にグルコシルサイクロデキストリンをアルデヒド
化した側鎖に2個のアルデヒド基を有するサイクロデキ
ストリンの物性値を示す。Table 1 shows the physical properties of cyclodextrin having two aldehyde groups in its side chain, which is obtained by converting glucosyl cyclodextrin into aldehyde.
Claims (3)
リンの分枝部のみをアルデヒド化させたアルデヒド化分
枝サイクロデキストリンを化学結合させたことを特徴と
する固定化サイクロデキストリン。(1) An immobilized cyclodextrin characterized in that an aldehyded branched cyclodextrin, in which only the branched portion of the branched cyclodextrin is aldehyded, is chemically bonded to a carrier having an amino group.
γ−サイクロデキストリンである請求項(1)記載の固
定化サイクロデキストリン。(2) The immobilized cyclodextrin according to claim (1), wherein the branched portion is a saccharide and the cyclic portion is α-, β- or γ-cyclodextrin.
たは蛋白質またはアミノ基含有合成高分子物質である請
求項(1)記載の固定化サイクロデキストリン。(3) The immobilized cyclodextrin according to claim (1), wherein the carrier having an amino group is an amino group-containing polysaccharide or protein, or an amino group-containing synthetic polymer substance.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20600989A JPH0368601A (en) | 1989-08-09 | 1989-08-09 | Immobil xized cyclodextrin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20600989A JPH0368601A (en) | 1989-08-09 | 1989-08-09 | Immobil xized cyclodextrin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0368601A true JPH0368601A (en) | 1991-03-25 |
Family
ID=16516399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP20600989A Pending JPH0368601A (en) | 1989-08-09 | 1989-08-09 | Immobil xized cyclodextrin |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0368601A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2850972A1 (en) * | 2003-02-07 | 2004-08-13 | Commissariat Energie Atomique | New per(3,6-anhydro)cyclodextrin derivatives useful for decontaminating metal-contaminated biological media and for preparing metal complexes for diagnostic or therapeutic use |
-
1989
- 1989-08-09 JP JP20600989A patent/JPH0368601A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2850972A1 (en) * | 2003-02-07 | 2004-08-13 | Commissariat Energie Atomique | New per(3,6-anhydro)cyclodextrin derivatives useful for decontaminating metal-contaminated biological media and for preparing metal complexes for diagnostic or therapeutic use |
| WO2004071639A3 (en) * | 2003-02-07 | 2004-10-07 | Commissariat Energie Atomique | Per (3,6-anhydro) cyclodextrine derivatives, production and use thereof in transporting metal elements to biological targets or in order to decontaminate biological fluids or targets |
| JP2006522840A (en) * | 2003-02-07 | 2006-10-05 | コミツサリア タ レネルジー アトミーク | Per (3,6-anhydro) cyclodextrin derivative, process for its preparation and its use for transporting metal elements to biological targets or for decontaminating biological targets or fluids |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kumar et al. | A comparative study on depolymerization of chitosan by proteolytic enzymes | |
| US4808232A (en) | Separation and purification of cyclodextrins | |
| EP0220719A2 (en) | Cyclodextrin absorbing material and its use | |
| EP2028487A1 (en) | Filler for optical isomer separation | |
| JPH02219571A (en) | Modified protease and production thereof | |
| US4904306A (en) | Separation and purification of gamma cyclodextrin | |
| JPH0587084B2 (en) | ||
| US5763598A (en) | Branched cyclodextrins and method for producing them | |
| JP4209617B2 (en) | Method for producing chitosan oligosaccharide and method for producing chitosan oligosaccharide alcohol | |
| JPH0368601A (en) | Immobil xized cyclodextrin | |
| Kubik et al. | Inclusion compounds of derivatized amyloses | |
| FI87464B (en) | FOERFARANDE FOER ISOLERING OCH RENING AV CYKLODEXTRINER. | |
| JP2003339393A (en) | Method for producing oligosaccharide (salt) | |
| JPH01167301A (en) | Purification of chitin or chitosan | |
| JPS6121102A (en) | Preparation of chitosan oligosaccharide | |
| CN1974604A (en) | Prepn process of branched cyclodextrin | |
| JP3816554B2 (en) | Novel branched cyclodextrin and method for producing the same | |
| JP4497592B2 (en) | Cyclodextrins having amino sugars in the branched side chain, process for producing the same, and use thereof | |
| JPH01285195A (en) | Production of difructose-cyanhydride | |
| Kubik et al. | Molecular inclusion within polymeric carbohydrate matrices | |
| JPH0368602A (en) | Cyclodextrin having formylated branch and preparation thereof | |
| JPS6121103A (en) | Preparation of chitosan oligosaccharide | |
| JP2571199B2 (en) | Method for producing highly soluble cyclodextrin | |
| CN111154010A (en) | Medical cationic polymer biopolymer material, preparation method and application | |
| US5273820A (en) | Separation and purification of cyclodextrins |